'Customers were not objects to suck blood from': Social relations in UK retail banks under changing performance management systems

Utilising an analytical framework informed by a moral economy approach, this article examines the social relationships between bank workers and customers in the context of changing performance management. Informed by 46 in‐depth interviews with branch workers and branch managers from UK banks, this article focusses on the interplay of the pressures arising from an intensified and all‐encompassing performance management system and bank workers lay morality. The article seeks to analyse why one group of bank workers engages with customers in a primarily instrumental manner, while another group tends to mediate and engage in oppositional practices which aim to avoid such an instrumentalisation. The article argues that moral economy gives voice to the agency of workers and the critical concerns of the social, economic and moral consequences of market‐driven and purely profit‐oriented workplace regimes

Trends in self-reported prevalence and management of hypertension, hypercholesterolemia and diabetes in Swiss adults, 1997-2007

Switzerland has a low mortality rate from cardiovascular diseases, but little is known regarding prevalence and management of cardiovascular risk factors (CV RFs: hypertension, hypercholesterolemia and diabetes) in the general population. In this study, we assessed 10-year trends in self-reported prevalence and management of cardiovascular risk factors in Switzerland. data from three national health interview surveys conducted between 1997 and 2007 in representative samples of the Swiss adult population (49,261 subjects overall). Self-reported CV RFs prevalence, treatment and control levels were computed. The sample was weighted to match the sex - and age distribution, geographical location and nationality of the entire adult population of Switzerland. self-reported prevalence of hypertension, hypercholesterolemia and diabetes increased from 22.1%, 11.9% and 3.3% in 1997 to 24.1%, 17.4% and 4.8% in 2007, respectively. Prevalence of self-reported treatment among subjects with CV RFs also increased from 52.1%, 18.5% and 50.0% in 1997 to 60.4%, 38.8% and 53.3% in 2007 for hypertension, hypercholesterolemia and diabetes, respectively. Self-reported control levels increased from 56.4%, 52.9% and 50.0% in 1997 to 80.6%, 75.1% and 53.3% in 2007 for hypertension, hypercholesterolemia and diabetes, respectively. Finally, screening during the last 12 months increased from 84.5%, 86.5% and 87.4% in 1997 to 94.0%, 94.6% and 94.1% in 2007 for hypertension, hypercholesterolemia and diabetes, respectively. in Switzerland, the prevalences of self-reported hypertension, hypercholesterolemia and diabetes have increased between 1997 and 2007. Management and screening have improved, but further improvements can still be achieved as over one third of subjects with reported CV RFs are not treated

Die Kontrolle der Hypertonie als primärpräventive Aufgabe.

Laaser U, Breckenkamp J. Die Kontrolle der Hypertonie als primärpräventive Aufgabe. In: Allhoff P, Flatten G, Laaser U, eds. Handbuch der Prävention. Berlin et al.: Springer Verlag; 1997: 267-280

Effect of age and type of testosterone treatment on cows used for heat detection

Cattlemen's Fate in '78 is known as Cattlemen’s Day, 1978Twelve cows were given a preliminary treatment of testosterone proprionate and were used to help us detect other cows in heat. We used two types of testosterone booster treatments to maintain male sex behavior in both age groups of cows. Two cows from each treatment or age group were paired and placed with 40 or 60 cows for 30 to 50 days. Two hundred forty-nine cows were observed in heat and 240 (96.4%) were marked by the detector cows. In this experiment, testosterone proprionate boosters maintained cows as heat detectors more effectively than testosterone enanthate boosters

A new tremelloid yeast isolated from <em>Asterophora lycoperdoides</em> (Bull.: Fr.) ditm.

Reports of a yeast stage of the homobasidiomycete Asterophora lycoperdoides were reexamined. Substantial differences in the physiological description and a gap of 11% G+C content were detected between the yeast and the mycelium. On the basis of nDNA reassociation experiments and restriction enzyme cleavage patterns of mtDNA using two different enzymes it has been concluded that the yeast strains and the mycelia are probably not the same species. The results of earlier reports about the life cycle, however, cannot be explained with these data. This yeast is newly described, because it shows unique physiological properties and no significant homology in DNA-DNA reassociation experiments to species it would normally be identified with in the literature. Because of its dolipore with cup-shaped parenthesome, we prefer the term tremelloid over assigning the strains to any existing genus, because no sexual structure or ballistospore has been observed so far

Global health ethics: an introduction to prominent theories and relevant topics

Global health ethics is a relatively new term that is used to conceptualize the process of applying moral value to health issues that are typically characterized by a global level effect or require action coordinated at a global level. It is important to acknowledge that this account of global health ethics takes a predominantly geographic approach and may infer that the subject relates primarily to macro-level health phenomena. However, global health ethics could alternatively be thought of as another branch of health ethics. It may then relate to specific topics in themselves, which might also include micro-level health phenomena. In its broadest sense, global health ethics is a normative project that is best characterized by the challenge of developing common values and universal norms for responding to global health threats. Consequently, many subjects fall within its scope. Whilst several accounts of global health ethics have been conceptualized in the literature, a concise demarcation of the paradigm is still needed. Through means of a literature review, this paper presents a two-part introduction to global health ethics. First, the framework of ‘borrowed’ ethics that currently form the core of global health ethics is discussed in relation to two essential ethical considerations: 1) what is the moral significance of health and 2) what is the moral significance of boundaries? Second, a selection of exemplar ethical topics is presented to illustrate the range of topics within global health ethics